Aladdin Education

An educational program on strategic
and regulatory science in paediatric
oncology drug development

Course on Strategic/Regulatory
Science in Paediatric Oncology
Drug Development.

360º Multi-stakeholder
Rotation.

Research Fellowship

Online Educational Portal

News

Prof Michel Zwaan discusses industry trials on the ALADDIN podcast

This week, we launched the newest ALADDIN podcast episode with Prof
Michel Zwaan, on the role of industry-led trials in developing new
medicines for children with cancer.

Why ALADDIN?

Developing new drugs for children with cancer is a complicated multi-step process that involves many different groups (academic researchers, pharmaceutical industry, patient advocates, regulatory authorities, …). There is a need to improve the efficiency of this process and fulfil the unmet needs of children with cancer.

What is our mission?

Accelerating drug development for childhood cancer through education.
ALADDIN is an educational program on strategic and regulatory science in paediatric oncology drug development to foster expertise and strengthen true multi-stakeholder collaboration. Through this project, individuals from various disciplines have the opportunity to learn about how to effectively navigate the regulatory science behind paediatric cancer drug development.